193 related articles for article (PubMed ID: 31356112)
1. Key Genes Involved in Diabetic Nephropathy Investigated by Microarray Analysis.
Liu X; Li X
J Comput Biol; 2019 Dec; 26(12):1438-1447. PubMed ID: 31356112
[TBL] [Abstract][Full Text] [Related]
2. Investigation of mechanisms of mesenchymal stem cells for treatment of diabetic nephropathy via construction of a miRNA-TF-mRNA network.
Yang H; Zhang X; Xin G
Ren Fail; 2018 Nov; 40(1):136-145. PubMed ID: 29532746
[TBL] [Abstract][Full Text] [Related]
3. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
Cao H; Rao X; Jia J; Yan T; Li D
Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
5. Identification of key microRNAs, transcription factors and genes associated with congenital obstructive nephropathy in a mouse model of megabladder.
Xin G; Chen R; Zhang X
Gene; 2018 Apr; 650():77-85. PubMed ID: 29410288
[TBL] [Abstract][Full Text] [Related]
6. Crucial genes associated with diabetic nephropathy explored by microarray analysis.
Wang Z; Wang Z; Zhou Z; Ren Y
BMC Nephrol; 2016 Sep; 17(1):128. PubMed ID: 27613243
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
[TBL] [Abstract][Full Text] [Related]
9. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
Qu W; Han C; Li M; Zhang J; Li L
Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
11. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.
Zhou G; Zhang X; Wang W; Zhang W; Wang H; Xin G
Med Sci Monit; 2019 Mar; 25():1903-1916. PubMed ID: 30865617
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
13. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
Wu T; Li Q; Wu T; Liu HY
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
[TBL] [Abstract][Full Text] [Related]
14. Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy.
Li B; Zhao X; Xie W; Hong Z; Cao Y; Zhang Y; Ding Y
BMC Med Genomics; 2024 May; 17(1):134. PubMed ID: 38764052
[TBL] [Abstract][Full Text] [Related]
15. Underlying Genes Involved in Atherosclerotic Macrophages: Insights from Microarray Data Mining.
Wang W; Zhang K; Zhang H; Li M; Zhao Y; Wang B; Xin W; Yang W; Zhang J; Yue S; Yang X
Med Sci Monit; 2019 Dec; 25():9949-9962. PubMed ID: 31875420
[TBL] [Abstract][Full Text] [Related]
16. PTGER3 and MMP-2 play potential roles in diabetic nephropathy via competing endogenous RNA mechanisms.
Yu Y; Jia YY; Wang M; Mu L; Li HJ
BMC Nephrol; 2021 Jan; 22(1):27. PubMed ID: 33435900
[TBL] [Abstract][Full Text] [Related]
17. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods.
Wang WN; Zhang WL; Zhou GY; Ma FZ; Sun T; Su SS; Xu ZG
Int J Mol Med; 2016 May; 37(5):1181-8. PubMed ID: 26986014
[TBL] [Abstract][Full Text] [Related]
20. Key Genes and Signaling Pathways Contribute to the Pathogensis of Diabetic Nephropathy.
Yang H; Lian D; Zhang X; Li H; Xin G
Iran J Kidney Dis; 2019 Mar; 13(2):87-97. PubMed ID: 30988245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
